Search

Day: August 1, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

August 1, 2023

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

August 1, 2023

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable

Socio-economic opportunities for women under spotlight

August 1, 2023

The acceleration of socio-economic programmes for women will take centre stage as the country commemorates Women’s Month.The Department of Women, Youth and Persons with Disabilities (DWYPD), in partnership with the Department of Sport, Arts and Cultur…

dtic hosts business editors ahead of BRICS

August 1, 2023

South Africa intends to bring the African agenda to the fore at the upcoming 15th BRICS Summit, which will take place in Johannesburg from 22 – 24 August.The Deputy Director-General of Exports at the Department of Trade, Industry and Competition (dtic…

Recent Post
Our Pages

Copyright © 2026 South Africa Insights. All Rights Reserved.